Newborn Screening for Lysosomal Storage Disorders

Area of Science:

• Public Health
• Genetics
• Pediatrics

Background:

• Newborn screening is a vital public health strategy for early detection of treatable infant diseases.
• Screening expands with new technologies and therapies, including for rare genetic disorders.
• Lysosomal storage disorders are emerging candidates for newborn screening programs.

Purpose of the Study:

• To critically review the current status of newborn screening for lysosomal storage disorders.
• To evaluate the feasibility and challenges of implementing newborn screening for these conditions.
• To assess the impact of screening on morbidity and mortality.

Main Methods:

• Literature review of current newborn screening practices.
• Analysis of technological advancements in screening methodologies.
• Evaluation of therapeutic options for lysosomal storage disorders.
• Assessment of challenges in identifying late-onset phenotypes.

Main Results:

• Lysosomal storage disorders are increasingly considered for newborn screening.
• Technological advancements facilitate broader screening capabilities.
• Significant challenges remain, particularly in identifying late-onset forms of these disorders.
• Early identification holds potential to reduce disease burden.

Conclusions:

• Newborn screening for lysosomal storage disorders is a developing area with significant potential.
• Addressing challenges like late-onset phenotypes is crucial for successful implementation.
• Further research and technological refinement are needed to optimize screening protocols.